| Title |
Interferon-α2b Treatment for COVID-19
|
|---|---|
| Published in |
Frontiers in immunology, May 2020
|
| DOI | 10.3389/fimmu.2020.01061 |
| Pubmed ID | |
| Authors |
Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, Zi-Hao Wang, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish |
X Demographics
The data shown below were collected from the profiles of 109 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 11 | 10% |
| United States | 10 | 9% |
| Canada | 7 | 6% |
| Ecuador | 5 | 5% |
| France | 3 | 3% |
| South Africa | 2 | 2% |
| Congo, The Democratic Republic of the | 2 | 2% |
| Uganda | 2 | 2% |
| Chile | 2 | 2% |
| Other | 20 | 18% |
| Unknown | 45 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 91 | 83% |
| Scientists | 13 | 12% |
| Practitioners (doctors, other healthcare professionals) | 3 | 3% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 466 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 466 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 58 | 12% |
| Researcher | 52 | 11% |
| Student > Master | 50 | 11% |
| Student > Ph. D. Student | 44 | 9% |
| Other | 36 | 8% |
| Other | 74 | 16% |
| Unknown | 152 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 81 | 17% |
| Biochemistry, Genetics and Molecular Biology | 43 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 7% |
| Immunology and Microbiology | 31 | 7% |
| Agricultural and Biological Sciences | 23 | 5% |
| Other | 80 | 17% |
| Unknown | 174 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 638. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2023.
All research outputs
#34,891
of 25,837,817 outputs
Outputs from Frontiers in immunology
#32
of 32,223 outputs
Outputs of similar age
#1,575
of 423,712 outputs
Outputs of similar age from Frontiers in immunology
#4
of 683 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,223 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,712 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 683 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.